Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CYP3A7 Antikörper (C-Term)

CYP3A7 Reaktivität: Human WB, ELISA, IHC (p) Wirt: Maus Monoclonal F19 P2 H2 unconjugated
Produktnummer ABIN533617
  • Target Alle CYP3A7 Antikörper anzeigen
    CYP3A7 (Cytochrome P450, Family 3, Subfamily A, Polypeptide 7 (CYP3A7))
    Bindungsspezifität
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 35
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 30
    • 5
    Maus
    Klonalität
    • 31
    • 4
    Monoklonal
    Konjugat
    • 22
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CYP3A7 Antikörper ist unkonjugiert
    Applikation
    • 23
    • 8
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Verwendungszweck
    Mouse monoclonal antibody raised against synthetic peptide of CYP3A7.
    Kreuzreaktivität
    Human
    Produktmerkmale
    Antibody Reactive Against Synthetic Peptide.
    Immunogen
    A synthetic peptide corresponding to C-terminus of human CYP3A7.
    Klon
    F19 P2 H2
    Isotyp
    IgG1
    Top Product
    Discover our top product CYP3A7 Primärantikörper
  • Applikationshinweise
    Western Blot (1-2 μg/mL)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1-5 μg/mL)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In PBS (0.08 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Kumarakulasingham, Rooney, Dundas, Telfer, Melvin, Curran, Murray: "Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 11, Issue 10, pp. 3758-65, (2005) (PubMed).

    Leeder, Gaedigk, Marcucci, Gaedigk, Vyhlidal, Schindel, Pearce: "Variability of CYP3A7 expression in human fetal liver." in: The Journal of pharmacology and experimental therapeutics, Vol. 314, Issue 2, pp. 626-35, (2005) (PubMed).

    Ogino, Nagata, Yamazoe: "Selective suppressions of human CYP3A forms, CYP3A5 and CYP3A7, by troglitazone in HepG2 cells." in: Drug metabolism and pharmacokinetics, Vol. 17, Issue 1, pp. 42-6, (2004) (PubMed).

  • Target
    CYP3A7 (Cytochrome P450, Family 3, Subfamily A, Polypeptide 7 (CYP3A7))
    Andere Bezeichnung
    CYP3A7 (CYP3A7 Produkte)
    Synonyme
    CP37 antikoerper, CYPIIIA7 antikoerper, P450-HFLA antikoerper, cytochrome P450, family 3, subfamily A, polypeptide 7 antikoerper, cytochrome P450 family 3 subfamily A member 7 antikoerper, CYP3A7 antikoerper
    Gen-ID
    1551
    Pathways
    Steroid Hormone Biosynthesis
Sie sind hier:
Kundenservice